Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer

In this study, we aimed to investigate the feasibility of serum Krebs von den Lungen-6 (KL-6) as a potential biomarker for treatment-related ILD (TR-ILD) in lung cancer. We recruited patients with lung cancer in whom KL-6 was measured to differentiate between pneumonia and ILD (category 1), diagnose...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hwa Kyung, Yoon, Chang-Seok, Na, Young-Ok, Lee, Jae-Kyeong, Oh, Hyung-Joo, Park, Ha-Young, Kho, Bo-Gun, Kim, Tae-Ok, Shin, Hong-Joon, Kwon, Yong-Soo, Oh, In-Jae, Kim, Yu-Il, Lim, Sung-Chul, Kim, Young-Chul, Park, Cheol-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593856/
https://www.ncbi.nlm.nih.gov/pubmed/37872370
http://dx.doi.org/10.1038/s41598-023-45170-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593856/
https://www.ncbi.nlm.nih.gov/pubmed/37872370
http://dx.doi.org/10.1038/s41598-023-45170-8

Ejemplares similares